IN8BIO, INC. — Director's Dealing 2024

Oct 8, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IN8BIO, INC. (INAB)
CIK: 0001740279
Period of Report: 2024-10-04

Reporting Person: FAIRBAIRN EMILY (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-10-04	Series C Warrants (right to buy)	$0.27	P	3038743	Acquired	2027-10-04	Common Stock (3038743)	Indirect
2024-10-04	Pre-Funded Warrants (right to buy)	$0.0001	P	3038743	Acquired		Common Stock (3038743)	Indirect

Footnotes

F1: Fully vested and exercisable.

F2: The reported securities are included within 3,038,743 Issuer Units purchased by the Reporting Person for $0.395 per Unit. Each Unit consists of one share Pre-funded warrant and one Series C warrant each representing the right to purchase 3,038,743 shares of common stock.

F3: The securities are held by the Malcolm and Emily Charitable Remainder Unitrust 2010 (the "Trust"). The Reporting Person is the trustee of the Trust.

F4: The Pre-funded warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder would beneficially own more than 4.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise.